Although the technique is probably the best currently available and has evolved considerably since the initial description (9), various problems with it (12-14) prompt the investigation of alternative approaches. In the several reports of the assessment of serial determinations of myoglobin during the course of human acute myocardial infarction (5, 8, (15) (16) (17) 
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and, when present in large amounts, has been detected in urine by colorimetry
(1), and more recently by immunological techniques (2, 3). Quantification of myoglobin in serum after myocardial infarction, first attempted by Kagen et al. (4) , is now done with much greater sensitivity by radio- 
Materials and Methods
The study was elevation in at least two adjacent electrocardiograph leads. Prospective study subjects had to meet the following additional criteria:
#{149} the first blood sample was obtained within 6 h of onset of pain of myocardial infarction #{149} age 72 years or less #{149} no previous myocardial infarction #{149} no intramuscular injection or other muscle trauma.
Intramuscular
injections were prohibited for the remainder of the study, and cardioversion, cut-down procedure, or other muscle trauma was cause for rejection.
A heparin lock was placed in a large free-flowing vein and serial 2-mL blood samples were obtained at 2-h intervals for 72-96 h. Samples were stored at 4 #{176}C, centrifuged, and the serum was stored at -20 #{176}C.
Myoglobins were measured as a batch for each patient, with use of the reagents and assay protocol of a doubleantibody technique involving lmIlabeled human myoglobin (Nuclear Medical Systems, Inc., Newport Beach, CA 92663). All samples were assayed in duplicate and the radioactivity was counted with a well-type scintillation counter. Antibody binding capacity (Ab) and equilibrium constant (K) were determined from a Scatchard plot (18) with computer optimization of upper and lower limits of counts bound (19).
where y is bound/total counts, and L is total ligand concentration, labeled and unlabeled.
The following data describe the assay characteristics in our laboratory: nonspecific binding, 6.8% The peak myoglobin concentration (mean ± SD) occurred at 9.9 ± 2.7 h after infarct onset, whereas peak CK occurred at 21.6 ± 4.0 h, significantly later (p < 0.0005, paired t-test) ( Table 1) To assess the duration of increases for the two markers, we determined the time from the onset of the infarct to the return of the serum value to twice the mean baseline value (66 zg/L for myoglobin and 200 U/L for CK). The mean (± SD) duration of myoglobin increase was 34.7 (± 14) h, whereas that for CK was 74.4 (± 14.6) h, significantly greater (p < 0.0005).
The mono-exponential disappearance rate (Kd) for CK was determined for each patient: mean ± SD = 0. 0.00029 min' (Table 1 ). The disappearance rate was well described by a mono-exponential function in every case, the mean r2 value being 0.9728 (SD 0.0341), with a range of 0.8864 to 0.9977. We also tried a bi-exponential analysis of the downslope data by using a computer program in which an exhaustion technique successively peels off more and more points from the curve; ifs bi-exponential expression could be developed for which i was greater than for the C K, creatine kinase; MGB, myoglobi n,Kd, exponentiaIdisappearancerate.
mono-exponential
expression, this would indicate that the bi-exonential expression gave a better description of the data. Seventeen of 21 patients had more than 10 downslope data points for CK, thus permitting a meaningful biexponential analysis; for only one of these 17 was the r2 value significantly increased.
The mean Kd for myoglobin was 0.00265 (SD 0.00097) min 1,significantly greater than that obtained for CK (p < 0.0005, paired t-test) ( Table 1 ). The mean r2 value was 0.9510 (SD 0.0753), with a range of 0.6634 to 0.9970. Biexponential analysis of the downslope data was conducted on the 14/21 patients who had more than 10 data points for myoglobin on the downslope. In only two cases was there a major improvement in the data fit as a result of bi-exponential analysis.
Discussion
In the present study, by means of early, frequent, and sustained blood sampling in a group of patients with confirmed acute myocardial infarction, we have developed a detailed and comprehensive picture of the time course of myoglobin concentrations in comparison with serial CK activity in the same patients. We have confirmed the early appearance of myoglobin in relation to CK, and have established the time from infarct onset to mean peak time (9.9 h for myoglobin vs 21.6 h for CK). We have demonstrated a correlation of peak values (r = 0.79), suggesting that the two markers reflect myocardial necrosis analogously. In spite of frequent sampling, we have not observed the "staccato" release phenomenon reported by Kagen et al. (15) . This phenomenon likely arose from insensitivity and lack of specificity in the immunological technique they used. In the present study the entry of increasing myoglobin into serum followed a smooth course analagous to that of CK; once the peak value was reached, decay was steady, rapid, and generally well described by an mono-exponential expression. In only two patients did a bi-exponential expression give a markedly better description of the disappearance. Myoglobin values decreased to twofold the baseline values after 34.7 h, as compared with 74.4 h for CK values.
Injection studies of myoglobin in humans (17) reveal a biexponential disappearance pattern with an external disappearance Kd many-fold greater than the Kd we calculated from the linear downslope of serial myoglobin curves in the present study. Therefore extensive myocardial myoglobin release beyond the point where the downslope of the serial myoglobin curve becomes linear on a semi-logarithmic plot is virtually certain. Accordingly, a cumulative myoglobin in the serum cannot be calculated by simple application of the concepts developed by Shel et al. for CK (11). Similar concern has arisen about the CK technique (22,23) .
The early increase of myoglobin would introduce an unpredictable error into the calculation of the cumulative myoglobin concentration in serum, but this error would be relatively small so long as at least one value was measured before the peak myoglobin value occurred. Although serial myoglobin determination might form the basis for an ideal technique of infarct size measurement for in-hospital infarction or experimental infarction in animals, the early appearance would be a serious drawback in studies of out-ofhospital infarction except in those patients admitted before the mean 9.9 h myoglobin peak time. (12) . We have recently shown marked variability in the fraction of CK released from the heart that enters the serum (serum entry ratio), depending on the size and type of infarction (14) . Others have shown such marked variability with re-perfusion that, clearly, the technique is not applicable in that setting (24, 25). The large potential error arising from variation of the serum entry ratio of CK might be less with myoglobin, for two reasons. First, the molecular mass of myoglobin being smaller than that of CK (17 800 vs 80 000 Da), the diffusion rate should therefore be faster, allowing less time for any local destruction and therefore allowing a greater proportion of the myoglobin to enter the serum. The rapid appearance and peaking of myoglobin observed in the present study support the likelihood of more rapid diffusion. Second, the immunological assay may permit proportionately greater peripheral recovery of myoglobin than is possible with CK, which is assayed by a biochemical activity that can be abolished by minor conformational or chemical alterations during exposure to cardiac lymph (26). The great variability of the serum entry ratio of CK is probably the weakest feature of the serial CK technique and the greatest potential advantage of the serial myoglobin technique. We have established the patterns of appearance and disappearance of myoglobin in comparison with patterns of CK in patients with acute myocardial infarction. Experimental animal studies and further studies in humans are indicated to delineate further the kinetics of myoglobin release and disappearance during the course of myocardial infarction.
